Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.39 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.39 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.39 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.39 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL425354 | 0.83 | ALDH1A1 (0.46) | ALDH1A1CA2POLBNR3C2SMN1; SMN2 | |
| SCHEMBL20679702 | 0.82 | KCNA5 (0.40) | ALDH1A1SMN1; SMN2CNR2NR3C1 | |
| SCHEMBL4441748 | 0.81 | CA2 (0.44) | ALDH1A1CA2POLBCNR2TSHR | |
| SCHEMBL20695962 | 0.80 | HSD11B1 (0.49) | ALDH1A1CA2POLBSMN1; SMN2CNR2 | |
| SCHEMBL20679708 | 0.80 | APLNR (0.63) | ALDH1A1SMN1; SMN2TSHRL3MBTL1 | |
| SCHEMBL20679713 | 0.78 | PYCR1 (0.42) | ALDH1A1SMN1; SMN2KMT2ANR3C1 | |
| SCHEMBL28852813 | 0.77 | ALDH1A1 (0.45) | ALDH1A1CA2POLBNR3C2SMN1; SMN2 | |
| SCHEMBL20679721 | 0.77 | CNR2 (0.63) | ALDH1A1POLBCNR2TSHRMCHR1 | |
| SCHEMBL20679707 | 0.77 | CRHBP (0.47) | ALDH1A1CA2TSHR | |
| SCHEMBL19189024 | 0.75 | NR3C2 (0.42) | ALDH1A1CA2POLBNR3C2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10933409-B2 | Transition metal complex containing sulfonamide or amide group for olefin metathesis reaction and application thereof | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2021-03-02 | — | — | US | disclosed |
| US-10933409-B2 | Transition metal complex containing sulfonamide or amide group for olefin metathesis reaction and application thereof | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2021-03-02 | — | — | US | disclosed |
| US-20190030521-A1 | TRANSITION METAL COMPLEX CONTAINING SULFONAMIDE OR AMIDE GROUP FOR OLEFIN METATHESIS REACTION AND APPLICATION THEREOF | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2019-01-31 | — | — | US | disclosed |
| US-20190030521-A1 | TRANSITION METAL COMPLEX CONTAINING SULFONAMIDE OR AMIDE GROUP FOR OLEFIN METATHESIS REACTION AND APPLICATION THEREOF | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2019-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10933409-B2 | Transition metal complex containing sulfonamide or amide group for olefin metathesis reaction and application thereof | TST, NBAS, TRRAP | ALDH1A1 3444/4885CA2 468/4885POLB 2902/4885 |
| US-20190030521-A1 | TRANSITION METAL COMPLEX CONTAINING SULFONAMIDE OR AMIDE GROUP FOR OLEFIN METATHESIS REACTION AND APPLICATION THEREOF | TST, NIT2, NBAS | ALDH1A1 2778/4885CA2 213/4885POLB 2447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.